January 2019

Dr. Cybulskis is an Assistant Professor of Biomedical and Chemical Engineering at Syracuse University....Read more

Virginijus Siksnys studied chemistry at Vilnius University and obtained his Ph.D from Moscow State University before returning to Vilnius where he moved through different research ranks at the Institute of Applied Enzymology/Institute of Biotechnology. Since 2002 he holds the position of Professor of Vilnius University and serves as Chief scientist at the Institute of Biotechnology. Dr. Siksnys has made a major and sustained contribution to the understanding of the structure and function of restriction enzymes. His research on the CRISPR-Cas has had a major impact on the field. His studies...Read more

Jim Thomas is a founding partner and CEO at Just Biotherapeutics, Inc. Jim is leveraging his extensive experience in biotechnology and scientific leadership to deliver the mission of Just. Over the course of his career, Jim’s passion has been to provide vital medicines to patients, and his vision for Just expands this to include patients worldwide.

Previously, Jim served as vice president of Process and Product Development within the Translational Sciences R&D organization at Amgen. In this role, he led the development and application of all process, analytical and formulation...Read more